o rl d SARS-CoV-2 ’s s t Flu A Flu B

4
One tube, primary screening of SARS-CoV-2, influenza A, influenza B and RSV A/B SARS-CoV-2 / Flu A / Flu B / RSV Assay W o rl d s 1 s t t e c h n o l o g y I n d i v i d u a l C t v a l u e o f m u l t i p l e a n a l y t e i n a s i n g l e c h a n n e l C E - I V D M a rk e d HIGH SENSITIVITY & SPECIFICITY Superior Multiplex real-time PCR with high sensitivity and specificity by Seegene’s innovative proprietary technologies ENGLISH

Transcript of o rl d SARS-CoV-2 ’s s t Flu A Flu B

Page 1: o rl d SARS-CoV-2 ’s s t Flu A Flu B

One tube, primary screening ofSARS-CoV-2, influenza A, influenza B and RSV A/B

SARS-CoV-2 / Flu A / Flu B / RSV Assay

World’s 1st technology Individual Ct value of multiple analyte in a single channel

CE-IV

D Marked

HIGH SENSITIVITY & SPECIFICITYSuperior

Multiplex real-time PCR with high sensitivity and speci�city by Seegene’s innovative proprietary technologies

ENG

LISH

Page 2: o rl d SARS-CoV-2 ’s s t Flu A Flu B

REALTIMEP C R M a r k e d

One tube, primary screening for SARS-CoV-2, in�uenza A, in�uenza B and RSV A/B

SARS-CoV-2 /Flu A/Flu B/RSV Assay

Allplex™ SARS-CoV-2/Flu A/Flu B/RSV Assay is a multiplex real-time PCR assay designed to detect N gene, RdRP gene and S gene for SARS-CoV-2, in�uenza A, in�uenza B and respiratory syncytial virus (RSV) A/B in a single tube. The assay is applied on Seegene’s All-in-One platform which enables high-throughput testing.

One tube test for COVID-19, Flu and RSV

Result within 2 hoursafter extraction

Auto-interpretation

High-throughput Automated platform

Self-collected sampleapplicable

Selected target of genesfrom WHO references

Dual wholeprocess controls

Detecting 3 target genes for SARS-CoV-2

6targets

SARS-CoV-2

FluA

Flu B

RSVA/B

6

Compatible Instrumentation (CE-IVD Marked)

- Automated Extraction & PCR SetupSeegene NIMBUSSeegene STARlet

Specimens- Nasopharyngeal swab

- Nasopharyngeal aspirate

- Bronchoalveolar lavage

- Throat swab

- Sputum

- Saliva

Analytes - SARS-CoV-2 (N gene)

- SARS-CoV-2 (S gene)

- SARS-CoV-2 (RdRP gene)

- Influenza A (Flu A)

- Influenza B (Flu B)

- Respiratory syncytial virus A/B (RSV A/B)

- Endogenous Internal Control (IC)

- Exogenous Internal Control (IC)

- Real-time PCRCFX96™ Dx

- Automated ExtractionNucliSENS® easyMAG®SEEPREP32™Maelstrom™ 9600MagNA Pure 96KingFisher™ Flex

-

Allplex™

Page 3: o rl d SARS-CoV-2 ’s s t Flu A Flu B

Testing for COVID-19 / Flu / RSV at once

Key features and bene�ts

Respiratory syndromic test for SARS-CoV-2, Flu A, Flu B and RSV A/B from one sample, which provides the solution for management of influenza-like illness patients

Providing dual internal control

- Exogenous internal control verifies the whole process from nucleic acid extraction to PCR steps

Endogenous internal control validates correct sampling, especially useful for testing self-collected specimens and minimizes false-negative result

-

-

-

-

High-throughput automated platform

Automated platform to minimize the risk of human-error and contamination in high-volume testing

Results within 2 hours after nucleic acid extraction

Allplex™ SARS-CoV-2/Flu A/Flu B/RSV Assay

Reliable result

-

-

Convenient data interpretation by Seegene Viewer

Simultaneous detection of 3 different target genes of SARS-CoV-2 to complement genetic variations, which allows high accuracy

No cross-reactivity confirmed with respiratory pathogens including SARS, MERS and SARS-related viruses

The example of SARS-CoV-2 and influenza A infection

2500

2000

1500

1000

500

0

0 10 20 30 40

RFU

Cycles

2500

2000

1500

1000

500

0

0 10 20 30 40

RFU

Cycles

2500

2000

1500

1000

500

0

0 10 20 30 40

RFU

Cycles

2500

2000

1500

1000

500

0

0 10 20 30 40

RFU

Cycles

Graph 1 Graph 2Channel

FAM

HEX

Cal Red 610

Quasar 670

FAM

HEX

Cal Red 610

Quasar 670

S gene

RdRP gene

��� 24.68

��� 26.13

2500

2000

1500

1000

500

0

0 10 20 30 40

RFU

Cycles

2500

2000

1500

1000

500

0

0 10 20 30 40

RFU

Cycles

2500

2000

1500

1000

500

0

0 10 20 30 40

RFU

Cycles

2500

2000

1500

1000

500

0

0 10 20 30 40

RFU

Cycles

FAM

HEX

Cal Red 610

Quasar 670

FAM

HEX

Cal Red 610

Quasar 670

N gene Flu A

Endo IC Exo IC

�� 26.27

�� 26.16

�� 25.39

�� 21.10

Multiple Ct value in a single channel

Seegene’s All-in-One automated platform

Automated interpretationSeegene Viewer

Real-time PCRCFX96™ Dx

Extraction & PCR SetupSeegene STARlet

Web-based statistical data analysis platform SG STATS

Data Analysis

Page 4: o rl d SARS-CoV-2 ’s s t Flu A Flu B

Product Cat. No.Volume

Allplex™ SARS-CoV-2/FluA/FluB/RSV Assay RV10260Y

RV10259X

50 rxns

100 rxns*

Ordering Information

Not Available for Sale in the United States

CFX96™ Dx ( 2 modules )

Instrument Cat. No.

1845097-IVD & 1841000-IVD

Seegene NIMBUS

Seegene STARlet

SEEPREP32™

65415-03

67930-03

SG71100

* For use with Seegene NIMBUS and Seegene STARlet only, ** For use with SEEPREP32™*** For use with Maelstrom™ 9600

STARMag 96 ProPrep (Plate type)**STARMag 96 ProPrep (Tube type)**

TANBEAD® Nucleic Acid Extraction kit***OptiPure Viral Auto Tube OptiPure Viral Auto PlateOptiPure Viral Bulk Plate

Maelstrom™ 9600 M9600

STARMag 96 x 4 viral DNA/RNA 200 C kit*

STARMag 96 ProPrep C (Plate type)**STARMag 96 ProPrep C (Tube type)**

EX00013C

STARMag 96 X 4 Universal Cartridge kit* 744300.4.UC384

EX00009PEX00009T

EX00017PEX00017T

W665S66W665A46W665A10

Highly speci�c ampli�cation technology for high multiplex PCR: DPO™

Allows the implementation of high multiplex diagnostics with unparalleled speci�city using Seegene’s unique primer structure

Ampli�cation

With Seegene’s core technologies and proprietary know-hows, enhance your MDx products with incomparable performance and usability.

Kick your Real-time PCR up a notch !

Oligo design technology for high multiplex PCR: SG-Insilico™

Enables rapid designing of high multiplex oligos using Seegene-developed algorithms and con�dential variables

Oligo DesignAI

High multiplex target detection &quanti�cation technology: MuDT™

Broadens capacity for high multiplex target detection & quanti�cation by enabling analysis of multiple Ct values in a single detection channel

Quantitative Detection

High multiplex signal processing technology: DSP™

Enables accurate reporting of target’s positive or negative results through Seegene’s proprietary signal processing algorithms

Interpretation

High multiplex target detection technology: TOCE™

Achieves accurate target signals by independently controlling multiple target signals for primer and probe annealing temperatures

Target Detection

Temperature

RV90

-EN

2101

08B-

01

BRAZILBelo Horizonte, BrazilTel : +55-31-25153003E-mail : [email protected]

Seegene Inc.Seoul, Republic of KoreaTel : +82-2-2240-4000E-mail : [email protected]

CANADAToronto, CanadaTel : +1-800-964-5680E-mail : [email protected]

GERMANY Düsseldorf, GermanyTel : +49-211-9943-4260E-mail : [email protected]

MEXICOMéxico city, MéxicoTel : + 52 (55)-8848-9646E-mail : [email protected]

ITALYGenova GE, ItalyTel : +39-010-667-1796E-mail : [email protected]

MIDDLE EASTDubai, UAETel : +971-4-558-7110E-mail : [email protected]

USACalifornia, USATel : +1-925-448-8172 E-mail : [email protected]

www.seegene.com

SARS-CoV-2/Flu A/Flu B/RSV Assay

ENG

LISH